Monica Seles, a tennis legend, has always been known for her tenacity on the court. However, in recent years, she’s faced a different kind of challenge—one that has changed her life both personally and professionally. Monica was diagnosed with myasthenia gravis (MG), a rare autoimmune disease that affects the communication between the nerves and muscles, leading to severe weakness and fatigue. In this blog post, we’ll explore Monica’s journey with MG, her partnership with Argenx for increased awareness, and the groundbreaking approval of Vyvgart Hytrulo for MG treatment. We’ll also take a closer look at the Go for Greater campaign and its impact on patient empowerment.
What is Myasthenia Gravis (MG)?
Myasthenia gravis is an autoimmune neuromuscular disorder that causes weakness in the voluntary muscles. It occurs when the body’s immune system mistakenly attacks the communication between the nerve and muscle cells. This results in symptoms like drooping eyelids, double vision, difficulty swallowing, and extreme muscle weakness, especially after prolonged activity. MG is considered a chronic condition, but with proper treatment, people can manage the disease and live fulfilling lives.
Monica Seles’ diagnosis was a turning point, not just in her personal life but also in her ability to continue with her career and active lifestyle. While the tennis star was known for her aggressive style of play, MG forced her to slow down and reevaluate her priorities.
Monica Seles’ Myasthenia Gravis Diagnosis Story
In a candid revelation, Monica Seles shared her personal journey with myasthenia gravis and how it took her by surprise. Diagnosed in her 40s, Seles was determined to continue her life in the public eye, but MG presented significant hurdles. The disease affected her muscles, including those needed for breathing and swallowing, which made it challenging for her to maintain her previous physical activity level.
Despite the difficulties, Monica’s spirit never wavered. She actively worked with medical professionals to find treatment options and gain a deeper understanding of the disease. By sharing her experience, she has become a beacon of hope for others with MG, showing that it’s possible to manage the condition while living an active and fulfilling life.
Argenx U.S. Open Sponsorship for MG Awareness
Monica’s partnership with Argenx, a global biotechnology company, has been pivotal in increasing awareness about myasthenia gravis. In 2025, Argenx made a splash by sponsoring the U.S. Open in a campaign aimed at raising awareness for MG. With Monica Seles as their spokesperson, the collaboration brought the spotlight to a rare disease that too often flies under the radar. The U.S. Open, a globally recognized sports event, served as an ideal platform for spreading the message to a wider audience, combining Monica’s fame with the need for patient education and empowerment.
Argenx’s sponsorship also highlighted the company’s commitment to improving the lives of people affected by MG through their innovative treatments. Their breakthrough drug, Vyvgart Hytrulo, has provided new hope for MG patients, offering a treatment option that helps manage symptoms more effectively.
Vyvgart Hytrulo: FDA Approval in 2025
A game-changer for MG patients, Vyvgart Hytrulo received FDA approval in 2025, marking a significant step forward in treating the autoimmune condition. This prefilled syringe formulation of Vyvgart is designed to help patients manage their symptoms more easily and conveniently. Vyvgart targets the root cause of MG, offering a novel approach to treatment that has already shown promising results in clinical trials.
For patients like Monica Seles, the approval of Vyvgart Hytrulo represents not just medical progress, but also the possibility of returning to a life of normalcy, where managing MG becomes easier and less disruptive. This development has inspired many in the MG community to continue their fight against the disease with renewed hope.
The Go for Greater Campaign
One of the most impactful aspects of Monica Seles’ partnership with Argenx is the Go for Greater campaign. This initiative is designed to empower myasthenia gravis patients by providing them with resources, information, and support to better manage their condition. The campaign focuses on encouraging patients to take charge of their health and pursue a greater quality of life despite the challenges posed by MG.
The campaign aims to raise awareness about MG, connect patients with healthcare professionals, and provide them with the tools they need to live healthier lives. By featuring Monica’s story, the Go for Greater campaign emphasizes the importance of understanding the disease and seeking proper treatment and support.
Myasthenia Gravis Patient Empowerment and Resources
Living with myasthenia gravis can be a daily struggle, but patient empowerment plays a crucial role in overcoming these challenges. Thanks to initiatives like the Go for Greater campaign, patients now have access to better resources and educational materials that can help them manage the disease effectively. From information about medications like Vyvgart Hytrulo to support groups and counseling, these resources offer a lifeline for those navigating life with MG.
Furthermore, the support from celebrities like Monica Seles helps normalize the conversation around rare diseases. By being open about her diagnosis, Monica has inspired countless others to speak up and seek the help they need. The goal is to create a world where those affected by MG are not only aware of their treatment options but are also empowered to lead fulfilling, active lives.
Read our previous post on Trump Federalizes DC Police Under Home Rule Act
FAQs
What are the symptoms of myasthenia gravis?
The symptoms of myasthenia gravis include muscle weakness, drooping eyelids, double vision, difficulty swallowing, and fatigue, especially after physical activity.
What causes myasthenia gravis?
Myasthenia gravis occurs when the body’s immune system attacks the communication between nerve cells and muscles, disrupting normal muscle function.
What is Vyvgart Hytrulo?
Vyvgart Hytrulo is a prefilled syringe formulation of a medication used to treat myasthenia gravis. It targets the root cause of the disease to manage symptoms effectively.
How can the Go for Greater campaign help MG patients?
The Go for Greater campaign offers resources, education, and patient support to help those with myasthenia gravis take control of their health and improve their quality of life.
Can myasthenia gravis be cured?
Currently, there is no cure for myasthenia gravis, but treatments like Vyvgart Hytrulo can help manage symptoms and improve the quality of life for patients.
Conclusion
Monica Seles’ story and her partnership with Argenx have brought much-needed attention to myasthenia gravis, an often-overlooked disease. With the support of organizations like Argenx and initiatives like the Go for Greater campaign, MG patients now have more hope than ever before. The FDA approval of Vyvgart Hytrulo further enhances this hope, offering a viable treatment option for those struggling with the disease. If you or someone you know is living with myasthenia gravis, it’s time to go for greater—seek support, explore treatment options, and continue fighting for a better tomorrow.
If you’ve found this article helpful, don’t forget to share it with others. Together, we can raise awareness and empower those affected by myasthenia gravis.
